QuickView for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=9A293F9B4FD554D3CFAA1B9898B171E8;jsessionid=C8B5755C1AB667BEC9CC28337B057DA7;jsessionid=D5F715532E1964E76539017D11BBDCAC;jsessionid=3F7151879880A3C9575406FF75D67AB2;jsessionid=7F77E1C69E3E8625E6162521E25C3BE1;jsessionid=BD9CAFA93692A43C9179D79AA1B42A56 (gene)

1. Thymic stroma and TFII-I: towards new targeted therapies.
2. Proteomic analysis of SRF associated transcription complexes identified TFII-I as modulator of SRF f…
3. Structural basis for evolutionarily conserved interactions between TFIIS and Paf1C.
4. The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and dis…
5. Identification of novel regulatory NFAT and TFII-I binding elements in the calbindin-D28k promoter i…

There were no clinical trials for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=9A293F9B4FD554D3CFAA1B9898B171E8;jsessionid=C8B5755C1AB667BEC9CC28337B057DA7;jsessionid=D5F715532E1964E76539017D11BBDCAC;jsessionid=3F7151879880A3C9575406FF75D67AB2;jsessionid=7F77E1C69E3E8625E6162521E25C3BE1;jsessionid=BD9CAFA93692A43C9179D79AA1B42A56